These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26613278)

  • 1. Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study.
    Podzolkova N; Tatarchuk T; Doshchanova A; Eshimbetova G; Pexman-Fieth C
    Gynecol Endocrinol; 2016; 32(3):246-9. PubMed ID: 26613278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of dydrogesterone in regularization of menstrual cycle: a post-marketing study.
    Trivedi N; Chauhan N; Vaidya V
    Gynecol Endocrinol; 2016 Aug; 32(8):667-671. PubMed ID: 26950060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dydrogesterone treatment for menstrual-cycle regularization in abnormal uterine bleeding - ovulation dysfunction patients.
    Wang L; Guan HY; Xia HX; Chen XY; Zhang W
    World J Clin Cases; 2020 Aug; 8(15):3259-3266. PubMed ID: 32874980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dydrogesterone in the regulation of cycle disturbances in adolescence].
    Chomczyk I; Sipowicz M; Sipowicz I
    Ginekol Pol; 1999 May; 70(5):343-7. PubMed ID: 10462978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of dydrogesterone in postpubertal menstruation disorders].
    Tabaste JL; Servaud M; Steiner E; Dabir P; Bene B; Pouzet M
    Rev Fr Gynecol Obstet; 1984 Jan; 79(1):19-20, 23-5. PubMed ID: 6531584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium.
    Schindler AE
    Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficacy of dydrogesterone in the treatment of menstrual cycle disorders in girls].
    Sipowicz I; Chomczyk I
    Ginekol Pol; 1998 Oct; 69(10):767-70. PubMed ID: 9884472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective post-laparoscopic treatment of endometriosis with dydrogesterone.
    Trivedi P; Selvaraj K; Mahapatra PD; Srivastava S; Malik S
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():73-6. PubMed ID: 17943543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of dydrogesterone for treatment of dysmenorrhea: An open-label multicenter clinical study.
    Taniguchi F; Ota I; Iba Y; Toda T; Tagashira Y; Ohata Y; Kurioka H; Endo Y; Sunada H; Noma H; Azuma Y; Harada T
    J Obstet Gynaecol Res; 2019 Jan; 45(1):168-175. PubMed ID: 30246276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dydrogesterone indications beyond menopausal hormone therapy: an evidence review and woman's journey.
    Stute P
    Gynecol Endocrinol; 2021 Aug; 37(8):683-688. PubMed ID: 33866898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, open-label, single-arm study to evaluate the efficacy of dydrogesterone in the treatment of endometrial polyps.
    Chen Q; Zhang D; Wang S; Lang JH; Chao XP; Fan QB
    Gynecol Endocrinol; 2021 Feb; 37(2):152-156. PubMed ID: 33274680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome.
    Khajehei M; Abdali K; Parsanezhad ME; Tabatabaee HR
    Int J Gynaecol Obstet; 2009 May; 105(2):158-61. PubMed ID: 19232611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of different progestogens on sleep in postmenopausal women: a randomized trial.
    Leeangkoonsathian E; Pantasri T; Chaovisitseree S; Morakot N
    Gynecol Endocrinol; 2017 Dec; 33(12):933-936. PubMed ID: 28609128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial responses to three different progestins in artificial cycles: a prospective, crossover study.
    Li TC; Aplin JD; Warren A; Graham RA; Dockery P; Cooke ID
    Fertil Steril; 1994 Jul; 62(1):191-3. PubMed ID: 8005290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of the premenstrual syndrome with a retroprogesterone (Duphaston)].
    Strecker JR
    Fortschr Med; 1980 Jan; 98(4):(145-7). PubMed ID: 7189174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial.
    Tomic V; Tomic J; Klaic DZ; Kasum M; Kuna K
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():49-53. PubMed ID: 25622239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The menstrual cycle regularization following D-chiro-inositol treatment in PCOS women: a retrospective study.
    La Marca A; Grisendi V; Dondi G; Sighinolfi G; Cianci A
    Gynecol Endocrinol; 2015 Jan; 31(1):52-6. PubMed ID: 25268566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of micronised vaginal progesterone versus oral dydrogestrone in the treatment of irregular dysfunctional uterine bleeding: a pilot randomised controlled trial.
    Karakus S; Kiran G; Ciralik H
    Aust N Z J Obstet Gynaecol; 2009 Dec; 49(6):685-8. PubMed ID: 20070724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.